Abiopharma

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

Illumina, Inc. - Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026

Crinetics Pharmaceuticals Announces January 2026 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Coherent Expands WaveShaper Portfolio With the New 1000A Sharp High-Resolution Programmable Optical Filter

Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes

SciSparc Notification (SPRC)

SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance